{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T14:45:43Z","timestamp":1770475543912,"version":"3.49.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1993,6,1]],"date-time":"1993-06-01T00:00:00Z","timestamp":738892800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Metast Rev"],"published-print":{"date-parts":[[1993,6]]},"DOI":"10.1007\/bf00689802","type":"journal-article","created":{"date-parts":[[2004,11,30]],"date-time":"2004-11-30T16:16:29Z","timestamp":1101831389000},"page":"73-82","source":"Crossref","is-referenced-by-count":95,"title":["The experimental development of bioreductive drugs and their role in cancer therapy"],"prefix":"10.1007","volume":"12","author":[{"given":"P.","family":"Workman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. J.","family":"Stratford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0360-3016(84)90301-8","volume":"10","author":"JE Moulder","year":"1984","unstructured":"Moulder JE, Rockwell S: Hypoxic fractions of solid tumours: experimental techniques, methods of analysis and a survey of existing data. Int J Radiat Oncol Biol Phys 10: 695?712, 1984","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0360-3016(88)90002-8","volume":"14","author":"RA Gatenby","year":"1988","unstructured":"Gatenby RA, Kessler HB, Rosenblum JS, Coia LR, Moldofsky PJ, Hartz WH, Broder GJ: Oxygen distribution in squamous cell carcinoma metastases and its relationship to the outcome of radiation therapy. Int J Radiat Oncol Biol Phys 14: 831?838, 1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR3","first-page":"3316","volume":"51","author":"P Vaupel","year":"1991","unstructured":"Vaupel P, Schlenger K, Knoop C, H\u00f6ckel M: Oxygenation of human tumours: Evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res 51: 3316?3322, 1991","journal-title":"Cancer Res"},{"key":"CR4","first-page":"6098","volume":"51","author":"M H\u00f6ckel","year":"1991","unstructured":"H\u00f6ckel M, Schlenger K, Knoop C, Vaupel P: Oxygenation of carcinomas of the uterine cervix: Evaluation by computerized O2 tension measurements. Cancer Res 51: 6098?6102, 1991","journal-title":"Cancer Res"},{"key":"CR5","first-page":"255","volume":"37","author":"RS Bush","year":"1978","unstructured":"Bush RS, Jenkin RDT, Allt WEC, Beale FA, Bean HA, Dembo AJ, Pringle JF: Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer 37: 255?258, 1978","journal-title":"Br J Cancer"},{"issue":"Suppl.","key":"CR6","first-page":"135","volume":"20","author":"S Dische","year":"1991","unstructured":"Dische S: Radiotherapy and anaemia: The clinical experience. Radiotherapy and Oncology 20: Suppl. 135?140, 1991","journal-title":"Radiotherapy and Oncology"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/0167-8140(92)90356-Y","volume":"24","author":"J Overgaard","year":"1992","unstructured":"Overgaard J: Importance of tumour hypoxia in radiotherapy: A meta-analysis of controlled clinical trials. Radiother Oncol 24: S64, 1992","journal-title":"Radiother Oncol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/bjc.1981.79","volume":"43","author":"JD Chapman","year":"1981","unstructured":"Chapman JD, Franko AJ, Sharplin J: A marker for hypoxic cells in tumours with potential clinical applicability. Br J Cancer 43: 546, 1981","journal-title":"Br J Cancer"},{"key":"CR9","first-page":"1523","volume":"43","author":"JD Chapman","year":"1983","unstructured":"Chapman JD, Baer K, Lee J: Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells. Cancer Res 43: 1523?1528, 1983","journal-title":"Cancer Res"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1259\/0007-1285-56-670-745","volume":"56","author":"BM Garrecht","year":"1983","unstructured":"Garrecht BM, Chapman JD: The labelling of EMT-6 tumours in BALB\/c mice with14C-misonidazole. Br J Radiol 56: 745?753, 1983","journal-title":"Br J Radiol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/978-1-4615-3768-7_29","volume-title":"Selective Activation of Drugs by Redox Processes","author":"JD Chapman","year":"1990","unstructured":"Chapman JD, Lee J, Meeker BE: Adduct formation by 2-nitroimidazole drugs in mammalian cells: optimization of markers for tissue oxygenation. In: Selective Activation of Drugs by Redox Processes (Eds. Adams GEet al.), Plenum Press, New York. pp 313?323, 1990"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0360-3016(86)90273-7","volume":"12","author":"RC Urtasun","year":"1986","unstructured":"Urtasun RC, Chapman JD, Raleigh JA, Franko AJ, Koch CJ: Binding of3H-misonidazole to solid human tumours as a measure of tumor hypoxia. Int J Radiat Oncol Biol Phys 12: 1263?1267, 1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0167-8140(91)90181-F","volume":"20","author":"JD Chapman","year":"1991","unstructured":"Chapman JD: Measurement of tumor hypoxia by invasive and non-invasive procedures: a review of recent clinical studies. Radiother Oncology, Suppl. 20: 13?19, 1991","journal-title":"Radiother Oncology, Suppl."},{"key":"CR14","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1021\/jm00111a049","volume":"34","author":"RJ Hodgkiss","year":"1991","unstructured":"Hodgkiss RJ, Jones GW, Long A, Middleton RW, Parrick J, Stratford MRL, Wardman P, Wilson GD: Fluorescent markers for hypoxic cells: A study of nitroaromatic compounds, with fluorescent heterocyclic side chains, that undergo bioreductive binding. J Med Chem 34: 2268?2274, 1991","journal-title":"J Med Chem"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1021\/jm00088a030","volume":"35","author":"RJ Hodgkiss","year":"1992","unstructured":"Hodgkiss RJ, Middleton RW, Parrick J, Rami HK, Wardman P, Wilson GD: Bioreductive fluorescent markers for hypoxic cells: A study of 2-nitroimidazoles with 1-substituents containing fluorescent, bridgehead-nitrogen, bicyclic systems. J Med Chem 35: 1920?1926, 1992","journal-title":"J Med Chem"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/0360-3016(89)90146-6","volume":"17","author":"JS Rasey","year":"1989","unstructured":"Rasey JS, Koh Wu-Jin, Grierson JR, Grunbaum ZMS, Krohn KA: Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia. Int J Radiat Oncol Biol Phys 17: 985?991, 1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2307\/3578246","volume":"132","author":"RH Mannan","year":"1992","unstructured":"Mannan RH, Mercer JR, Wiebe LI, Somayaji VV, Chapman JD: Radioiodinated 1-(2-fluoro-4-iodo-2,4-dideoxy-?-1-xylopyranosyl)-2-nitroimidazole: A novel probe for the noninvasive assessment of tumor hypoxia. Rad Res 132: 368?374, 1992","journal-title":"Rad Res"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/bjc.1992.17","volume":"65","author":"MB Parliament","year":"1992","unstructured":"Parliament MB, Chapman JD, Urtasun RC, McEwan AJ, Golberg L, Mercer JR, Mannan RH, Wiebe LI: Non-invasive assessment of human tumour hypoxia with123I-iodoazomycin arabinoside: preliminary report of a clinical study. Br J Cancer 65: 90?95, 1992","journal-title":"Br J Cancer"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2307\/3577905","volume":"129","author":"L Kwock","year":"1992","unstructured":"Kwock L, Gill M, McMurry HL, Beckman W, Raleigh JA, Joseph AP: Evaluation of a fluorinated 2-nitroimidazole binding to hypoxic cells in tumor-bearing rats by19F magnetic resonance spectroscopy and immunohistochemistry. Rad Res 129: 71?78, 1992","journal-title":"Rad Res"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.STR.18.1.168","volume":"18","author":"JM Hoffman","year":"1987","unstructured":"Hoffman JM, Rasey JS, Spence AM, Shaw DW, Krohn KA: Binding of the hypoxia tracer [3H]misonidazole in cerebral ischemia. Stroke 18: 168?176, 1987","journal-title":"Stroke"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0024-3205(87)90494-2","volume":"44","author":"CJ Mathias","year":"1987","unstructured":"Mathias CJ, Welch MJ, Kilbourn MR, Jerabek PA, Patrick TB, Raichle ME, Krohn KA, Rasey JS, Shaw W: Radiolabelled hypoxic cell sensitizers: tracers for assessment of ischemia. Life Sci 44: 199?206, 1987","journal-title":"Life Sci"},{"key":"CR22","first-page":"3501","volume":"34","author":"RM Sutherland","year":"1974","unstructured":"Sutherland RM: Selective chemotherapy of non-cycling cells in anin vitro tumour model. Cancer Res 34: 3501?3503, 1974","journal-title":"Cancer Res"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1148\/117.2.453","volume":"117","author":"EJ Hall","year":"1975","unstructured":"Hall EJ, Roizin-Towle L: Hypoxic sensitizers: Radiobiological studies at the cellular level. Radiology 117: 453?457, 1975","journal-title":"Radiology"},{"key":"CR24","first-page":"930","volume":"36","author":"JK Mohindra","year":"1976","unstructured":"Mohindra JK, Rauth AM: Increased cell killing by metronidazole and nitrofurazone of hypoxic compared to aerobic mammalian cells. Cancer Res 36: 930?936, 1976","journal-title":"Cancer Res"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2307\/3574342","volume":"67","author":"BA Moore","year":"1976","unstructured":"Moore BA, Palcic B, Skarsgard LD: Radiosensitizing and toxic effects of the 2-nitroimidazole Ro-07-0582 in hypoxic mammalian cells. Rad Res 67: 459?473, 1976","journal-title":"Rad Res"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0006-291X(76)80207-0","volume":"72","author":"GE Adams","year":"1976","unstructured":"Adams GE, Clarke ED, Jacobs RS, Stratford IJ, Wallace RG, Wardman P, Watts ME: Mammalian cell toxicity of nitro compounds: Dependence upon reduction potential. Biochem Biophys Res Comm 72: 824?829, 1976","journal-title":"Biochem Biophys Res Comm"},{"key":"CR27","first-page":"555","volume":"64","author":"GE Adams","year":"1980","unstructured":"Adams GE, Stratford IJ, Wallace RG, Wardman P, Watts ME: Toxicity of nitro compounds toward hypoxic mammalian cells: Dependence upon reduction potential. J Natl Cancer Inst 64: 555?560, 1980","journal-title":"J Natl Cancer Inst"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/bjc.1980.166","volume":"41","author":"YC Taylor","year":"1980","unstructured":"Taylor YC, Rauth AM: Sulphydryls, ascorbate and oxygen as modifiers of the toxicity and metabolism of misonidazolein vitro. Br J Cancer 41: 892?900, 1980","journal-title":"Br J Cancer"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1021\/bi00679a013","volume":"14","author":"RP Mason","year":"1975","unstructured":"Mason RP, Holtzman JL: The mechanism of microsomal and mitochondrial nitroreductase. Electron spin resonance evidence for nitroaromatic free radical intermediates. Biochemistry 14: 1626?1632, 1975","journal-title":"Biochemistry"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/0360-3016(86)90267-1","volume":"12","author":"EM Zeman","year":"1986","unstructured":"Zeman EM, Brown JM, Lemmon MJ, Hirst VK, Lee WW: SR 4233: A new bioreductive agent with high selective toxicity for hypoxic mammalian cells. Int J Radiat Oncol Biol Phys 12: 1239?1242, 1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR31","first-page":"440","volume":"40","author":"DV Lloyd","year":"1991","unstructured":"Lloyd DV, Duling DR, Rumyantseva GA, Mason RP, Bridson PK: Microsomal reduction of 3-amino-1,2,4-benzotriazine 1,4-dioxide to a free radical. Mol Pharmacol 40: 440?445, 1991","journal-title":"Mol Pharmacol"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/bjc.1989.364","volume":"60","author":"P Workman","year":"1989","unstructured":"Workman P, Walton MI, Powis G, Schlager JJ: DT-diaphorase questionable role in mitomycin C resistance, but a target for novel bioreductive drugs? Br J Cancer 60: 800?802, 1989","journal-title":"Br J Cancer"},{"key":"CR33","first-page":"4692","volume":"50","author":"PR Hoban","year":"1990","unstructured":"Hoban PR, Walton MI, Robson CN, Godden J, Stratford IJ, Workman P, Harris AL, Hickson D: Decreased NADPH: Cytochrome P-450 reductase activity and impaired drug activation in a mammalian cell line resistant to mitomycin C under aerobic but not hypoxic conditions. Cancer Res 50: 4692?4697, 1990","journal-title":"Cancer Res"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/0360-3016(89)90900-0","volume":"16","author":"MI Walton","year":"1989","unstructured":"Walton MI, Wolf CR, Workman P: Molecular enzymology of the reductive bioactivation of hypoxic cell cytotoxins. Int J Radiat Oncol Biol Phys 16: 983?986, 1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0360-3016(92)90493-2","volume":"22","author":"P Workman","year":"1992","unstructured":"Workman P: Bioreductive mechanisms. Int J Radiat Oncol Biol Phys 22: 631?637, 1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/0006-2952(87)90181-X","volume":"36","author":"MI Walton","year":"1987","unstructured":"Walton MI, Workman P: Nitroimidazole bioreductive metabolism. Quantitation and characterisation of mouse tissue benzonidazole nitroreductasesin vivo andin vitro. Biochem Pharmacol 36: 887?896, 1987","journal-title":"Biochem Pharmacol"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/bjc.1990.161","volume":"61","author":"JCM Bremner","year":"1990","unstructured":"Bremner JCM, Stratford IJ, Bowler J, Adams GE: Bioreductive drugs and the selective induction of tumour hypoxia. Br J Cancer 61: 717?721, 1990","journal-title":"Br J Cancer"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/bjc.1984.91","volume":"49","author":"GE Adams","year":"1984","unstructured":"Adams GE, Ahmed I, Sheldon PW, Stratford IJ: Radiation sensitization and chemoptentiation: RSU 1069, a compound more efficient than misonidazolein vitro andin vivo. Br J Cancer 49: 571?577, 1984","journal-title":"Br J Cancer"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.2307\/3577675","volume":"124","author":"S Cole","year":"1990","unstructured":"Cole S, Stratford IJ, Adams GE, Fielden EM, Jenkins TC: Dual function 2-nitroimidazoles and hypoxic cell radiosensitizers and bioreductive cytotoxins:In vivo evaluation in KHT murine sarcomas. Rad Res 124: S38-S43, 1990","journal-title":"Rad Res"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0360-3016(92)90510-O","volume":"22","author":"GE Adams","year":"1992","unstructured":"Adams GE, Stratford IJ, Edwards HS, Bremner JCM, Cole S: Bioreductive drugs as post-irradiation sensitizers: Comparison of dual function agents with SR 4233 and the mitomycin C analogue EO9. Int J Radiat Oncol Biol Phys 22: 717?720, 1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2307\/3577481","volume":"116","author":"S Rockwell","year":"1988","unstructured":"Rockwell S, Keyes SR, Sartorelli AC: Preclinical studies of porfiromycin as an adjunct to radiotherapy. Rad Res 116: 100?113, 1988","journal-title":"Rad Res"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0360-3016(90)90276-P","volume":"18","author":"EM Zeman","year":"1990","unstructured":"Zeman EM, Lemmon MJ, Brown JM: Aerobic radiosensitization by SR 4233in vitro andin vivo. Int J Radiat Biol Phys 18: 125?132, 1990","journal-title":"Int J Radiat Biol Phys"},{"key":"CR43","first-page":"7745","volume":"50","author":"JM Brown","year":"1990","unstructured":"Brown JM, Lemmon MJ: Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumours. Cancer Res 50: 7745?7749, 1990","journal-title":"Cancer Res"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0167-8140(91)90203-S","volume":"20","author":"JM Brown","year":"1991","unstructured":"Brown JM, Lemmon MJ: SR 4233: A tumour specific radiosensitizer active in fractionated regimes. Radiother Oncol (Suppl) 20: 151?156, 1991","journal-title":"Radiother Oncol (Suppl)"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0360-3016(91)90057-B","volume":"20","author":"JM Brown","year":"1991","unstructured":"Brown JM, Lemmon MJ: Tumour hypoxia can be exploited to preferentially sensitize tumours to fractionated radiation. Int J Radiat Oncol Biol Phys 20: 457?461, 1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1\/2","key":"CR46","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/09553009114551911","volume":"60","author":"JM Brown","year":"1991","unstructured":"Brown JM: Targeting bioreductive drugs to tumours: is it necessary to manipulate blood flow? Int J Radiat Biol 60: 1\/2, 231?236, 1991","journal-title":"Int J Radiat Biol"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/09553008914550451","volume":"55","author":"IJ Stratford","year":"1989","unstructured":"Stratford IJ, Adams GE, Godden J, Howells N: Induction of tumour hypoxia post-irradiation: a method for increasing the sensitizing efficiency of misonidazole and RSU 1069in vivo. Int J Radiat Biol 55: 3, 411-422, 1989","journal-title":"Int J Radiat Biol"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0360-3016(82)90691-5","volume":"8","author":"NJ McNally","year":"1982","unstructured":"McNally NJ: Enhancement of chemotherapy agents. Int J Radiat Oncol Biol Phys 8: 593?598, 1982","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/0360-3016(84)90508-X","volume":"10","author":"DW Siemann","year":"1984","unstructured":"Siemann DW: Modification of chemotherapy by nitroimidazoles. Int J Radiat Oncol Biol Phys 10: 1585?1594, 1984","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/bjc.1984.92","volume":"49","author":"FYF Lee","year":"1984","unstructured":"Lee FYF, Workman P: Misonidazole and CCNU; Further evidence for a pharmacokinetic mechanism of chemosensitization and therapeutic gain. Br J Cancer 49: 579?585, 1984","journal-title":"Br J Cancer"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/bjc.1990.295","volume":"62","author":"DW Sieman","year":"1990","unstructured":"Sieman DW: Enhancement of chemotherapy and nitroimidazole-induced chemopotentiation by the vasoactive agent hydralazine. Br J Cancer 62: 348?353, 1990","journal-title":"Br J Cancer"},{"key":"CR52","first-page":"3528","volume":"48","author":"CN Coleman","year":"1988","unstructured":"Coleman CN, Carlson RW, Halsey J, Kohler M, Gribble BI, Jacobs C: Enhancement of the clinical activity of melphalan by the hypoxic cell sensitizer misonidazole. Cancer Res 48: 3528?3532, 1988","journal-title":"Cancer Res"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/jnci\/84.3.187","volume":"84","author":"SA Holden","year":"1992","unstructured":"Holden SA, Teicher GA, Ara G, Herman TS, Coleman CN: Enhancement of alkylating agent activity by SR 4233 in the FSaIIC murine fibrosarcoma. J Natl Cancer Inst 84: 187?193, 1992","journal-title":"J Natl Cancer Inst"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-1-4615-3768-7_16","volume-title":"Selective Activation of Drugs by Redox Processes","author":"P Workman","year":"1990","unstructured":"Workman P, Walton MI: Enzyme-directed bioreductive drug development. In: Selective Activation of Drugs by Redox Processes (Eds Adams GE, Breccia A, Wardman P, Fielden EM), pp 173?191, Plenum Press, New York, 1990"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/0006-2952(90)90119-6","volume":"37","author":"MI Walton","year":"1990","unstructured":"Walton MI, Workman P: Enzymology of the reductive bioactivation of SR 4233: A novel benzotriazine di-N-oxide hypoxic cell cytotoxin. Biochem Pharmacol 37: 1735?1742, 1990","journal-title":"Biochem Pharmacol"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0006-2952(93)90251-Q","volume":"45","author":"RJ Riley","year":"1993","unstructured":"Riley RJ, Hemingway SA, Graham MA, Workman P: Initial characterization of the major mouse P450 isoenzymes involved in the reductive metabolism of the hypoxic cytotoxin, 3-animo-1,2,4-benzotriazine-1,4-dioxide (SR 4233, WIN 59075). Biochem Pharmacol 45: 1065?1077, 1993","journal-title":"Biochem Pharmacol"},{"key":"CR57","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/carcin\/11.8.1407","volume":"11","author":"A Cahill","year":"1990","unstructured":"Cahill A, White INH: Reductive metabolism of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233) and the induction of unscheduled DNA synthesis in rat and human derived cell lines. Carcinogenesis 11: 1401?1411, 1990","journal-title":"Carcinogenesis"},{"key":"CR58","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0006-2952(92)90007-6","volume":"44","author":"MI Walton","year":"1992","unstructured":"Walton MI, Wolf CR, Workman P: The role of cytochrome P450 and cytochrome P450 reductase in the reductive bioactivation of the novel benzotriazine di-N-dioxide hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233, WIN 59075) by mouse liver. Biochem Pharmacol 44: 251?259, 1992","journal-title":"Biochem Pharmacol"},{"key":"CR59","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/0006-2952(88)90010-X","volume":"37","author":"K Laderoute","year":"1988","unstructured":"Laderoute K, Wardman P, Rauth AM: Molecular mechanisms for the hypoxia-dependent activation of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233). Biochem Pharmacol 37: 1487?1495, 1988","journal-title":"Biochem Pharmacol"},{"key":"CR60","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0006-2952(92)90274-M","volume":"43","author":"RJ Riley","year":"1992","unstructured":"Riley RJ, Workman P: Enzymology of the reduction of the potent benzotriazine di-N-oxide hypoxic cell cytotoxin SR 4233 (WIN 59075) by NAD(P)H:(quinone acceptor) oxidoreductase (EC 1.66.99.2) purified from Walker 256 rat tumour cells. Biochem Pharmacol 43: 167?174, 1992","journal-title":"Biochem Pharmacol"},{"key":"CR61","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-2952(93)90067-7","volume":"45","author":"A Cahill","year":"1993","unstructured":"Cahill A, Jenkins TC, White INH: Metabolism of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233) by purified DT-diaphorase under aerobic and anaerobic conditions. Biochem Pharmacol 45: 321?329, 1993","journal-title":"Biochem Pharmacol"},{"key":"CR62","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/bjc.1993.59","volume":"67","author":"J Wang","year":"1993","unstructured":"Wang J, Biedermann KA, Wolf CR, Brown JM: Metabolism of the bioreductive cytotoxin SR 4233 by tumour cells: enzymatic studies. Br J Cancer 67: 321?325, 1993","journal-title":"Br J Cancer"},{"key":"CR63","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/bjc.1991.85","volume":"63","author":"KA Biedermann","year":"1991","unstructured":"Biedermann KA, Wang J, Graham RP, Brown JM: SR 4233 cytotoxicity and metabolism in DNA repair-competent and repair deficient cell cultures. Br J Cancer 63: 358?362, 1991","journal-title":"Br J Cancer"},{"key":"CR64","first-page":"4473","volume":"52","author":"J Wang","year":"1992","unstructured":"Wang J, Biedermann KA, Brown JM: Repair of DNA and chromosome breaks in cells exposed to SR 4233 under hypoxia or to ionizing radiation. Cancer Res 52: 4473?4477, 1992","journal-title":"Cancer Res"},{"key":"CR65","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0304-3835(78)80034-2","volume":"5","author":"NA Schor","year":"1978","unstructured":"Schor NA, Ogawa K, Lee G, Farber E: The use of DT-diaphorase for the detection of foci of early neoplastic transformation in rat liver. Cancer Lett 5: 167?171, 1978","journal-title":"Cancer Lett"},{"key":"CR66","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ijc.2910450304","volume":"45","author":"JJ Schlager","year":"1990","unstructured":"Schlager JJ, Powis G: Cytosolic NAD(P)H:(quinone acceptor) oxidoreductase in human normal and tumour tissue. Effects of cigarette smoking and alcohol. Int J Cancer 45: 403?409, 1990","journal-title":"Int J Cancer"},{"key":"CR67","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0006-2952(91)90284-C","volume":"42","author":"T Cresteil","year":"1991","unstructured":"Cresteil T, Jaiswal AK: High levels of expression of the NAD(P)H:(quinone acceptor) oxidoreductase (NQO1) gene in tumour cells compared to normal cells of the same origin. Biochem Pharmacol 42: 1021?1027, 1991","journal-title":"Biochem Pharmacol"},{"key":"CR68","first-page":"4752","volume":"52","author":"AM Malkinson","year":"1992","unstructured":"Malkinson AM, Siegel D, Forrest GL, Gazdar AF, Oie HK, Chan DC, Bunn PA, Mabry M, Dykes DJ, Harrison SD, Ross D: Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: Relationship to the response of lung tumor xenografts to mitomycin C. Cancer Res 52: 4752?4757, 1992","journal-title":"Cancer Res"},{"key":"CR69","first-page":"7483","volume":"50","author":"D Siegel","year":"1990","unstructured":"Siegel D, Gibson NW, Preusch PC, Ross D: Metabolism of mitomycin C by DT-diaphorase: Role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells. Cancer Res 50: 7483?7489, 1990","journal-title":"Cancer Res"},{"key":"CR70","first-page":"7293","volume":"50","author":"D Siegel","year":"1990","unstructured":"Siegel D, Gibson NW, Preusch PC, Ross D: Metabolism of diaziquinone by NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase): Role in diaziquinone-induced DNa damage and cytotoxicity in human colon carcinoma cells. Cancer Res 50: 7293?7300, 1990","journal-title":"Cancer Res"},{"key":"CR71","first-page":"5638","volume":"44","author":"SR Keyes","year":"1984","unstructured":"Keyes SR, Facasso PM, Heimbrook DC, Rockwell S, Sligar S, Sartorelli AC: Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C. Cancer Res 44: 5638?5643, 1984","journal-title":"Cancer Res"},{"key":"CR72","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0304-3835(89)90073-6","volume":"45","author":"A Begleiter","year":"1989","unstructured":"Begleiter A, Robotham E, Lacey G, Leith MK: Increased sensitivity of quinone resistant cells to mitomycin C. Cancer Lett 45: 173?176, 1989","journal-title":"Cancer Lett"},{"key":"CR73","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0006-2952(92)90429-M","volume":"44","author":"N Robertson","year":"1992","unstructured":"Robertson N, Stratford IJ, Houlbrook S, Carmichael J, Adams GE: The sensitivity of human tumour cells to quinone bioreductive drugs: What role for DT-diaphorase? Biochem Pharmacol 44: 409?412, 1992","journal-title":"Biochem Pharmacol"},{"key":"CR74","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0360-3016(92)90495-4","volume":"22","author":"MI Walton","year":"1992","unstructured":"Walton MI, Suggett N, Workman P: The role of human and rodent DT-diaphorase in the reductive metabolism of hypoxic cell cytotoxins. Int J Radiat Oncol Biol Phys 22: 643?648, 1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR75","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3727\/095535491820873164","volume":"3","author":"MI Walton","year":"1991","unstructured":"Walton MI, Smith PJ, Workman P: The role of NAD(P) H:quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumour agent EO9. Cancer Comm 3: 199?206, 1991","journal-title":"Cancer Comm"},{"key":"CR76","first-page":"10","volume":"28A","author":"MI Walton","year":"1992","unstructured":"Walton MI, Bibby MC, Double JA, Plumb JA, Workman P: DT-diaphorase activity correlates with sensitivity to the indoloquinone EO9 in mouse and mouse colon carcinomas. Eur J Cancer 28A: 10, 1597?1600, 1992","journal-title":"Eur J Cancer"},{"key":"CR77","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0360-3016(92)90496-5","volume":"22","author":"SM Bailey","year":"1992","unstructured":"Bailey SM, Suggett N, Walton MI, Workman P: Structureactivity relationships for DT-diaphorase reduction of hypoxic cell directed agents: Indoloquinones and diaziridinyl benzoquinones. Int J Radiat Oncol Biol Phys 22: 649?654, 1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR78","first-page":"802","volume-title":"Radiation Research: A 20th Century Perspective","author":"GE Adams","year":"1992","unstructured":"Adams GE, Bremner JCM, Edwards HS, Fielden EM, Naylor M, Stratford IJ, Wood P: Bioreductive drugs: Dual function agents and related compounds. In: Radiation Research: A 20th Century Perspective, Vol. II (Eds Dewey WC, Edington M, Fry RJM, Hall EJ, Whitmore GF). Academic Press, San Diego, 802?806, 1992"},{"key":"CR79","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0360-3016(89)90898-5","volume":"16","author":"IJ Stratford","year":"1989","unstructured":"Stratford IJ, Stephens MA: The differential hypoxic cytotoxicity of bioreductive agents determinedin vitro by the MTT assay. Int J Radiat Oncol Biol Phys 16: 973?977, 1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR80","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1021\/jm00127a035","volume":"32","author":"EOM Orlemans","year":"1989","unstructured":"Orlemans EOM, Verboom W, Schaltinga MW, Reinhoudt DN, Lelieveld P, Fiebig HH, Winterhalter BR, Double JA, Bibby MC: Synthesis, mechanism of action, and biological evaluation of mitosenes. J Med Chem 32: 1612?1620, 1989","journal-title":"J Med Chem"},{"key":"CR81","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1021\/jm00156a001","volume":"29","author":"WA Denny","year":"1986","unstructured":"Denny WA, Wilson WR: Considerations for the design of nitrophenyl mustards as agents with selective toxicity for hypoxic tumour cells. J Med Chem 29: 879?887, 1986","journal-title":"J Med Chem"},{"key":"CR82","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1016\/0006-2952(88)90335-8","volume":"37","author":"RJ Knox","year":"1988","unstructured":"Knox RJ, Friedlos F, Jarman M, Roberts JJ: A new cytotoxic, DNA interstrand crosslinking agent, 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide, is formed from 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by a nitroreductase enzyme in Walker carcinoma cells. Biochem Pharmacol 37: 4661?4669, 1988","journal-title":"Biochem Pharmacol"},{"key":"CR83","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1021\/jm00089a027","volume":"35","author":"GH Kwon","year":"1992","unstructured":"Kwon GH, Blanco DR, Batway N: p-(methyl sulfinyl) phenyl nitrogen mustard as a novel bioreductive prodrug selective against hypoxic tumours. J Med Chem 35: 2137?2139, 1992","journal-title":"J Med Chem"},{"key":"CR84","unstructured":"Ware DC, Wilson WR, Denny WA, Rickard LEF: Design and synthesis of Cobalt (III) nitrogen mustard complexes as hypoxia selective cytotoxins. J Chem Soc Chem Comm 1171-1174, 1991"},{"key":"CR85","first-page":"796","volume-title":"DNA binding nitroheterocycles as hypoxia-selective cytotoxins in ?Radiation Research: A 20th century perspective. Vol II?","author":"WR Wilson","year":"1992","unstructured":"Wilson WR, Denny WA: DNA binding nitroheterocycles as hypoxia-selective cytotoxins in ?Radiation Research: A 20th century perspective. Vol II?. Eds Dewey WC, Edington M, Fry RJM, Hall EJ, Whitmore GF. Academic Press, San Diego, 796?801, 1992"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00689802.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00689802\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00689802","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T18:40:58Z","timestamp":1554835258000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00689802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,6]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1993,6]]}},"alternative-id":["BF00689802"],"URL":"https:\/\/doi.org\/10.1007\/bf00689802","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,6]]}}}